Comment on this story

0 Comments on this story



Post comments

Email to a friend




Send email

Related Jobs

Chris Mario joins Neuropharm from Wyeth

19 Jan 2009

Medical Affairs

Chris Mario has moved from Wyeth Pharmaceuticals to become brand leader within Neuropharm Group's US unit, it has been announced.

Ms Mario was executive director of US and global marketing at Wyeth's biopharma business unit and before that was head of US marketing at Sanofi-Aventis subsidiary Dermik Laboratories.

She will now become brand leader of NPL-2008, Neuropharm's novel autism treatment which is currently in phase-three trials.

The firm expects to receive results from the clinical research in the first quarter of the year and hopes to submit the drug for US Food and Drug Administration approval in the second quarter.

"We are delighted that Chris has joined our team in the US. She has deep experience in marketing and new product introductions and a strong appreciation for the unique needs of paediatric patients," said Bob Prachar, president of US operations at Neuropharm.

This month, positive results from the firm's trials of a treatment for fragile X syndrome were published in the Journal of Medical Genetics.


Bookmark and Share

0 comments on this story